New Zealand Pro-Life Group Opposes Family Planning Bid to Sell Abortion Drug
by Steven Ertelt
March 23, 2009
Wellington, New Zealand (LifeNews.com) — A pro-life group in New Zealand is mounting public opposition to a bid by the Family Planning Council to distribute the dangerous abortion drug mifepristone. FPC says abortion should be more available across the island nation and it wants to distribute the drug that has killed women worldwide.
The council has submitted an application to the Abortion Supervisory Committee for a license to distribute the abortion pill.
Mifepristone, also known as RU 486, has killed more than a dozen women worldwide and injured more than 1,400 in the United States alone.
Andy Moore, the director of Pro-Life New Zealand, says his group is opposed to granting the application to provide the abortion drug at its 30 locations in part because FPC is allowed in New Zealand schools.
"It is unethical for a group to be in our schools promoting abortion as a preferable option, and then turning around and offering the service at their clinics," he said.
"RU-486 has by no means been proven to be safe for women, and yet this is the drug that the Family Planning Association is intending to use if its application is granted," he continued.
Moore also tells LifeNews.com that making the abortion pill more available will only drive up the number of abortions on the island nation. He notes that there are 26 abortion centers operating in New Zealand.
"Our abortion rate is already through the roof, with over 18,000 abortions performed in New Zealand every year, and the trend is upwards," he said. "Their claim that an additional 30 clinics would not increase the total number of abortions is absolutely ridiculous. It will do nothing to reduce the unacceptably high number of New Zealand abortions."
FPC indicated it would use the dangerous abortion drug on women up to 9 weeks into the pregnancy to take the lives of their unborn children.
It also indicated it would use the ulcer medication Cytotec, whose maker has specifically instructed not be used in association with abortions because it is not made for that purpose, as the second part of the abortion drug process.
The first part, known as Mifegyne in New Zealand, essentially deprives the developing baby of nutrition from her mother and starves the child to death. Cytotec is then used for its side effect of causing contractions and the mother gives birth to a deceased baby.
Abortions are already on the rise in New Zealand thanks to taxpayer funding of them.
The Abortion Supervisory Committee issued a report in December indicating there were 18,382 abortions in 2007, which is an increase of 448 from the 2006 figures.
The report showed the country having 19.6 abortions a year per 1000 women aged 15-44.
Because New Zealand law requires two physicians to sign off on any abortion and allows for taxpayer funding of the abortion and the practitioners, the committee found the government paid 196 abortion practitioners and consultants a total of $5,048,096.
Because of the increase in the number of abortions and physician fees, that is a an increase of $1.5 million or more than 30 percent higher than the figure from four years ago.
More than 98 percent of abortions were approved on mental health grounds even though worldwide research — and studies in New Zealand — show abortions themselves cause women a plethora of mental health problems.
The Zealand Right to Life group has complained about the high rate of approved abortions for mental health reasons and a High Court judicial review found reason to doubt the lawfulness of the abortions.
The Abortion Supervisory Committee appealed the decision and Right to Life appealed a second ruling. The case will likely be up for another hearing later this year.
Sign Up for Free Pro-Life News From LifeNews.com
Daily Pro-Life News Report Twice-Weekly Pro-Life
News Report Receive a free daily email report from LifeNews.com with the latest pro-life news stories on abortion, euthanasia and stem cell research. Sign up here. Receive a free twice-weekly email report with the latest pro-life news headlines on abortion, euthanasia and stem cell research. Sign up here.